Galectins at the maternal-fetal interface: shield or gateway to infections?
- 1Laboratório de Investigação em Dermatologia e Imunodeficiências LIM56, Instituto de Medicina Tropical, Faculdade de Medicina FMUSP, Universidade de São Paulo , , ,
Abstract
Pregnancy relies on a tightly regulated immune balance at the maternal-fetal interface, where tolerance toward the semi-allogeneic fetus must coexist with effective defense mechanisms against invading pathogens. In this context, galectins (gals), a family of β-galactoside-binding lectins, play essential roles in placentation, angiogenesis, tissue remodeling, and immune regulation. Beyond their physiological functions, accumulating evidence indicates that these proteins also participate in host-virus interactions, acting either to restrict infection or to facilitate viral attachment, entry, replication, and persistence. In this review, we discuss the structural characteristics, unconventional secretion pathways, and major immunological functions of gal, with particular emphasis on gal-1, gal-3, gal-9 and gal-13, at the maternal-fetal interface. We also summarize the current evidence regarding their involvement in congenital infections caused by cytomegalovirus (CMV), Zika virus (ZIKV), and human immunodeficiency virus (HIV). Available studies indicate that gals modulate key processes, including viral entry, immune cell activation, inflammation, viral persistence, and maternal-fetal transmission, although their specific mechanisms of action within the placenta remain poorly understood. Collectively, the available evidence suggests that gals exert dual and context-dependent functions, acting as critical regulators of the delicate balance between immune tolerance and antiviral defense. A better understanding of these mechanisms may contribute to the identification of novel biomarkers and improve our understanding of the pathogenesis of congenital infections, ultimately leading to better pregnancy outcomes.
Related
- Characterization of Resolved, Localized, and Progressing Infections at the Maternal-Fetal Interface in a Nonhuman Primate Model
- Maternal thyroid status and immune adaptation at the maternal-fetal interface: distinguishing direct from indirect pathways
- The maternal–fetal interface is an early hematopoietic niche enriched in distinct erythro-myeloid progenitors
- Alternative splicing of CD244 restrains natural killer cells at the maternal-fetal interface
- Cell-type-specific expression of classical and membrane progesterone receptors at the human maternal-fetal interface
BibTeX
@article{mattos2026galectins,
title = {{Galectins at the maternal-fetal interface: shield or gateway to infections?}},
author = {Gabriela Domingues Mattos and Nátalli Zanete Pereira and Maria Notomi Sato},
journal = {Frontiers in cellular and infection microbiology},
year = {2026},
month = oct,
doi = {10.3389/fcimb.2026.1960770},
url = {https://europepmc.org/article/PMC/PMC13728874},
note = {CC BY},
}
RIS
TY - JOUR
TI - Galectins at the maternal-fetal interface: shield or gateway to infections?
AU - Gabriela Domingues Mattos
AU - Nátalli Zanete Pereira
AU - Maria Notomi Sato
PY - 2026
DA - 2026/10/20
JO - Frontiers in cellular and infection microbiology
DO - 10.3389/fcimb.2026.1960770
UR - https://europepmc.org/article/PMC/PMC13728874
AB - Pregnancy relies on a tightly regulated immune balance at the maternal-fetal interface, where tolerance toward the semi-allogeneic fetus must coexist with effective defense mechanisms against invading pathogens. In this context, galectins (gals), a family of β-galactoside-binding lectins, play essential roles in placentation, angiogenesis, tissue remodeling, and immune regulation. Beyond their physiological functions, accumulating evidence indicates that these proteins also participate in host-virus interactions, acting either to restrict infection or to facilitate viral attachment, entry, replication, and persistence. In this review, we discuss the structural characteristics, unconventional secretion pathways, and major immunological functions of gal, with particular emphasis on gal-1, gal-3, gal-9 and gal-13, at the maternal-fetal interface. We also summarize the current evidence regarding their involvement in congenital infections caused by cytomegalovirus (CMV), Zika virus (ZIKV), and human immunodeficiency virus (HIV). Available studies indicate that gals modulate key processes, including viral entry, immune cell activation, inflammation, viral persistence, and maternal-fetal transmission, although their specific mechanisms of action within the placenta remain poorly understood. Collectively, the available evidence suggests that gals exert dual and context-dependent functions, acting as critical regulators of the delicate balance between immune tolerance and antiviral defense. A better understanding of these mechanisms may contribute to the identification of novel biomarkers and improve our understanding of the pathogenesis of congenital infections, ultimately leading to better pregnancy outcomes.
SN - 2235-2988
ER -